- Investing Ideas
- /
- Australian Pharmaceuticals & Biotech Established, Profitable and Undervalued
Australian Pharmaceuticals & Biotech Established, Profitable and Undervalued
UPDATED Aug 12, 2022
Over $1bn in market cap, profitable and undervalued based on cash flows.
1 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
| CSLCSL | AU$292.85 | -1.3% | -1.6% | AU$141.1b | AU$311.37 | PE43.1x | E15.1% | 1.1% |
Page 1 of 1